Lisata Therapeutics Inc. (LSTA)
NASDAQ: LSTA
· Real-Time Price · USD
2.52
-0.04 (-1.56%)
At close: Aug 15, 2025, 3:59 PM
2.53
0.40%
After-hours: Aug 15, 2025, 04:00 PM EDT
Lisata Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -4.66M | -4.72M | -4.61M | -4.93M | -5.04M | -5.4M | -5.37M | -5.26M | -4.03M | -6.19M | -5.99M | -37.38M | -6.63M | -4.23M | -6.79M | -6.93M | -5.68M | -8.06M |
Depreciation & Amortization | 44K | 43K | 41K | 42K | 45K | 46K | 47K | 47K | 47K | 48K | 47K | 8K | 7K | 7K | 8K | 14K | 17K | 16K |
Stock-Based Compensation | 239K | 530K | 871.76K | 327K | 237.00 | 454K | 473K | 307K | 583K | 675K | 468K | 1.04M | 368K | 760K | 366K | 772K | 270K | 597K |
Other Working Capital | -296K | 449K | -703K | 1.97M | 562K | -831K | -366K | 860K | 441K | -1.49M | 453K | 833K | 286K | -912K | -23K | 310K | -42K | -848K |
Other Non-Cash Items | -20K | -41K | -1.19M | -61K | 103.76K | -52K | -1.08M | -283K | -584K | -164K | -105K | 30.39M | 385K | 515K | 589K | 792K | 810K | 323K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | 826K | n/a | 325K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 440K | -1.21M | 358K | 2.1M | -388K | -2.07M | 1.03M | 1.61M | -528K | -2.57M | -888K | 1.95M | 804K | -2.7M | 1.23M | 310K | -42K | -848K |
Operating Cash Flow | -3.96M | -5.4M | -4.53M | -2.52M | -5.28M | -7.03M | -4.07M | -3.58M | -4.18M | -8.2M | -6.47M | -4M | -5.06M | -5.64M | -4.6M | -5.04M | -4.63M | -7.97M |
Capital Expenditures | -28K | -28K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -26K | -24K | -235K | n/a | -60K | n/a | -60K | n/a |
Cash Acquisitions | n/a | n/a | 130K | -30K | n/a | -100K | n/a | n/a | n/a | n/a | 3.32M | -3.32M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -4.13M | -5.08M | -11.73M | -15.34M | -9.79M | -18.82M | -21.12M | -16.52M | -30.71M | -30.12M | -21.21M | -38.19M | -3.75M | -26.55M | -42.45M | -31.54M | -29.88M | -75.91M |
Sales Maturities Of Investments | 4.63M | 14.51M | 13.12M | 9.16M | 21.4M | 25.36M | 15.41M | 28.77M | 29.99M | 34.41M | 28.34M | 33.8M | 39.61M | 20.46M | 58.9M | 36.48M | 18.74M | 10.82M |
Other Investing Acitivies | 28K | 28K | -130K | -100K | 100K | n/a | n/a | n/a | -725 | 4.29K | -3.32M | 10M | -10M | -6.09K | 60K | 4.94K | -11.14K | -65.09K |
Investing Cash Flow | 505K | 9.43M | 1.39M | -6.3M | 11.71M | 6.44M | -5.71M | 12.25M | -725K | 4.29M | 7.11M | 2.26M | 25.63M | -6.09M | 16.46M | 4.94M | -11.2M | -65.09M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | 142.00 | n/a | -142K | n/a | -6K | n/a | -85 | n/a | -99 | n/a | -168 | n/a | -64 | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -10K | -243K | -132K | n/a | n/a | n/a | n/a | n/a | 452K | -85K | n/a | -99K | n/a | -168K | n/a | -64K | n/a | -160K |
Financial Cash Flow | 64K | -23K | -96K | n/a | 32K | -142K | 24K | -6K | 452K | -85K | 14K | -99K | 29K | -168K | 21K | -64K | 22K | 85.3M |
Net Cash Flow | -3.38M | 4.01M | -3.3M | -8.78M | 6.49M | -788K | -9.84M | 8.74M | -4.46M | -4M | 676K | -1.87M | 20.6M | -11.9M | 11.88M | -163K | -15.81M | 12.23M |
Free Cash Flow | -3.96M | -5.4M | -4.53M | -2.52M | -5.28M | -7.03M | -4.07M | -3.58M | -4.18M | -8.2M | -6.49M | -4.02M | -5.3M | -5.64M | -4.66M | -5.04M | -4.69M | -7.97M |